Tracheobronchial Replacement
Emmanuel Martinod(Inserm), Éric Vicaut(Université Paris Cité), Guillaume Lebreton(Inserm), Olivier Huet(Baker Heart and Diabetes Institute), Y. Uzunhan(Assistance Publique – Hôpitaux de Paris), Ilaria Onorati(Inserm), Xavier Chapalain(Centre Hospitalier Régional Universitaire de Brest), Ana Maria Santos Portela(Sorbonne Université), Guillaume Van Der Meersch(Hôpital Avicenne), Marine Peretti(Sorbonne Université), Dana M. Radu(Inserm), Hélène Rouard(Inserm), Christophe Trésallet(Sorbonne Université), Boris Duchemann(Université Paris-Saclay), Kader Chouahnia(Sorbonne Université), Sadek Béloucif(Sorbonne Université), Géraud Galvaing(Centre Jean Perrin), Jean-Baptiste Chadeyras(Centre Jean Perrin), Charles Juvin(Sorbonne Université), François Tronc, Olivia Freynet(Sorbonne Université), Nicolas Vénissac(Centre Hospitalier Universitaire de Lille), Paulina Kuczma(Assistance Publique – Hôpitaux de Paris)
Cited by 5
Related Papers
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
|The Lancet|2013|1.2k
Sarcoidosis
|The Lancet|2013|1.1k
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
|The Lancet Respiratory Medicine|2020|477
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke
|New England Journal of Medicine|2018|363
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
|European Respiratory Journal|2017|296